课题基金 / 基金详情

IMMUNOTHERAPY OF HUMAN CANCER

IMMUNOTHERAPY OF HUMAN CANCER
人类癌症的免疫治疗
批准号：
3813454
负责人：
R J HODES
金额：
$0.0万
依托单位：
DIVISION OF CANCER BIOLOGY AND DIAGNOSIS
依托单位国家：
美国
项目类别：
财政年份：
--
资助国家：
美国
项目状态：
未结题
起止时间：
至
来源：
https://reporter.nih.gov/project-details/3813454
关键词：
biological response modifiers human subject human therapy evaluation immunomodulators melanoma neoplasm /cancer chemotherapy neoplasm /cancer classification /staging neoplasm /cancer immunology neoplasm /cancer immunotherapy

项目摘要

项目成果

R J HODES的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
A controlled, randomized trial comparing immunotherapy to chemotherapy in stage I and stage II malignant melanoma has been initiated. A total of 181 patients have entered the trial, which is closed to further accrual of patients. Preliminary evaluation of data has demonstrated no significant effect of adjuvant therapies on clinical course.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
REGULATION OF LYMPHOCYTE PROLIFERATION AND CELL CYCLE PROGRESSION
T CELL REGULATION AND B CELL ACTIVATION
RECEPTOR MEDIATED T AND B CELL ACTIVATION
IMMUNE RESPONSE GENE REGULATION OF IMMUNE RESPONSE IN VITRO
海外基金